Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
J Gen Intern Med
.
2022 May;37(6):1554-1557.
doi: 10.1007/s11606-021-06838-x.
Epub 2021 May 28.
Authors
Arman A Shahriar
1
,
Gabriela Vazquez Benitez
2
,
Pamala A Pawloski
2
,
Steven P Dehmer
2
,
Jonathan D Alpern
2
3
Affiliations
1
University of Minnesota Medical School, Minneapolis, MN, USA. shahr019@umn.edu.
2
HealthPartners Institute, Bloomington, MN, USA.
3
Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
PMID:
34047918
PMCID:
PMC9086023
DOI:
10.1007/s11606-021-06838-x
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Drug Costs
Drugs, Generic
Humans
Prescription Drugs*
Prescriptions
United States
Substances
Drugs, Generic
Prescription Drugs